REIN THERAPEUTICS, INC. (RNTX) Operating income 2016–2025
REIN THERAPEUTICS, INC. (RNTX) annual operating income history from SEC filings — each fiscal year as reported.
-$50.6MFY2025 · since FY2016: -$18.2M → -$50.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.6M | +22.2% |
| FY2024 | -$65.1M | -300.0% |
| FY2023 | -$16.3M | +41.1% |
| FY2022 | -$27.6M | -3.9% |
| FY2021 | -$26.6M | -29.8% |
| FY2020 | -$20.5M | +31.6% |
| FY2019 | -$30.0M | +6.1% |
| FY2018 | -$31.9M | -38.7% |
| FY2017 | -$23.0M | -26.6% |
| FY2016 | -$18.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice